Magnolia Capital Advisors LLC Senseonics Holdings, Inc. Transaction History

Magnolia Capital Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$0.5 - $1.05 $12,500 - $26,250	25,000 New	25,000 $15,000
Q4 2022 Feb 13, 2023	BUY	$0.96 - $1.34 $24,000 - $33,500	25,000 New	25,000 $26,000
Q2 2022 Aug 15, 2022	BUY	$0.94 - $1.94 $4,700 - $9,700	5,000 Added 7.34%	73,102 $75,000
Q1 2022 May 16, 2022	BUY	$1.54 - $3.71 $12,173 - $29,327	7,905 Added 13.13%	68,102 $134,000
Q4 2021 Jan 26, 2022	BUY	$2.58 - $3.91 $98,548 - $149,350	38,197 Added 173.62%	60,197 $161,000
Q3 2021 Nov 10, 2021	BUY	$2.77 - $4.05 $60,940 - $89,100	22,000 New	22,000 $75,000
Q1 2021 May 14, 2021	SELL	$0.85 - $5.27 $56,100 - $347,820	-66,000 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$0.36 - $0.95 $23,750 - $62,675	65,974 Added 253746.16%	66,000 $58,000
Q3 2020 Nov 02, 2020	SELL	$0.36 - $0.53 $23,750 - $34,966	-65,974 Reduced 99.96%	26 $26,000
Q2 2020 Jul 30, 2020	BUY	$0.39 - $0.69 $11,700 - $20,700	30,000 Added 83.33%	66,000 $26,000
Q4 2019 Mar 31, 2020	BUY	$0.83 - $1.3 $29,880 - $46,800	36,000 New	36,000 $32,000

136

60.1M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $475M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Magnolia Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Magnolia Capital Advisors LLC with notifications on news.